Andres Perez Lopez
FAAP, MD
Consultant Pediatrician Director of Outpatient Infusion Center
Years of Experience: 28
Dr. Andrés Pérez-López has been a Senior Attending Physician in Microbiology at Sidra Medicine since 2017. Before joining Sidra Medicine, Dr. Pérez-López worked as a Consultant Microbiologist and Infection Control Doctor for five years for the National Health Service in England and Scotland. Previously, he worked as a consultant pediatrician and lead clinician for pediatric infectious diseases for nine years at Manacor Hospital in Spain.
Dr Pérez-López has played a pivotal role in implementing novel and cost-effective diagnostic tests for infectious diseases and optimizing antimicrobial prescribing practices at Sidra Medicine. He has also authored more than 30 publications in international peer-reviewed journals, mainly focused on the molecular characterization of antimicrobial resistance mechanisms in the pediatric population of Qatar using whole-genome sequencing.
Read more
- English
- Spanish
- Ph.D. Pediatrics, Autonomous University of Barcelona, Spain, 2003
- M.B.A. Applied Microbiology, Autonomous University of Barcelona, Spain, 2003
- Specialist certificate in Clinical Microbiology and Parasitology, Germans Trias i Pujol Hospital, Spain, 2003
- M.B.A. Infectious Diseases, Autonomous University of Barcelona, Spain, 1999
- Specialist certificate in Pediatrics, Dr Miguel Pérez Carreño, Venezuela, 1996
- M.B.B.S, Central University of Venezuela, 1990
- Molecular epidemiology of multidrug-resistant pathogens
- Novel diagnostic techniques for Infectious Diseases
- Antimicrobial stewardship
- Infection Control and Prevention
- Medical Education
- Quality Improvement
- Letter to the editor regarding the article: Diarrhea don’ts: reducing inappropriate stool cultures and ova and parasite testing for nosocomial diarrhea. Am J Infect Control 2023; 51: 1291-3.
- Urinary tract infections in children from the Gulf Cooperation Council countries: a literature review (2011–2022). Front Pediatr 2023; 11: 1163103.
- Molecular characterization of Candida auris outbreak isolates in Qatar from COVID-19 patients reveals the emergence of isolates resistant to three classes of antifungal drugs. Clin Microbiol Infect 2023; 29: 1083.e1-1083.e7.
- Letter to the editor regarding the article: comparison of obstetric to institutional antibiogram as an approach to advance antimicrobial stewardship in maternal care. J Matern Fetal Neonatal Med 2023; 36: 2191774.
- Resurgence of influenza A infections in children after the relaxation of COVID-19-related social distancing measures and normalization of international travel in Qatar. J Travel Med 2022; 29: taac107.
Clinics & Services
Our Insurance Partners
Our Insurance Partners
